|

Ersodetug Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 3: 1

Top Sponsors

  • Rezolute1

Indications

  • Tumor Hyperinsulinism (Tumor HI)1
  • Cancer1

Chicago, Illinois1 trial

A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism

Investigative Site

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.